Funding · Company
Volastra Therapeutics, Inc.
New York, NYBiotech & Pharma
Volastra Therapeutics, Inc. of New York, NY has disclosed $90M across 2 Form D offerings filed with the SEC between Mar 13, 2023 and Sep 23, 2025.
$90M
Total disclosed
2
Form D offerings
1
Open roles today
Hiring — 1 open role as of Sep 5, 2026
Based in New York, NY. Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersNew York, NYIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001968822Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →